YDW-16815-70666
5 vaccinations
4 coded responses
31 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 405 / KY
- Registered
- 2021-01-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Dose 1 — Moderna
-
2021-01-10
Registered in v-safe
-
2021-01-10
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Fair · Site: PainFree text: Shingles - onset 3 days prior to vaccine, however diagnosed 2 days following vaccinationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-21
- 2021-01-28
-
2021-02-04
Dose 2 — Moderna
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-05-06
- 2021-08-05
-
2021-10-29
Dose 3 — Moderna
-
2022-02-04
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-06-10
Dose 4 — Moderna
- 2022-06-30
- 2022-07-01
-
2022-07-08
Survey response — day 28, dose 4MedDRA: Foetal growth restriction, Ultrasound scan abnormal — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Intrauterine growth fetal restriction diagnosed on ultrasound done 7/1/22MedDRA releases: 2024-11 · check-in free text available
-
2022-07-08
Report sent to call center — day 28, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-07-11
-
2022-07-11
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-07-15
- 2022-07-22
-
2022-09-11
Survey response — 3 months, dose 4MedDRA: Delivery, Postpartum state — Feeling: GoodFree text: Postpartum. Delivered baby on (b)(6)/22MedDRA releases: 2024-11 · check-in free text available
-
2022-09-12
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-12-12
- 2022-12-15
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Moderna | |
| 2 | 2021-02-04 | Moderna | |
| 3 | 2021-10-29 | Moderna | No |
| 4 | 2022-06-10 | Moderna | No |
| 5 | 2022-09-12 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-08 | Successful 2022-07-11 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Shingles - onset 3 days prior to vaccine, however diagnosed 2 days following vaccination
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Release 12 — day 28, dose 4
Symptoms: Intrauterine growth fetal restriction diagnosed on ultrasound done 7/1/22
Release 12 — 3 months, dose 4
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Foetal growth restriction | · | · | ✓ |
| SD | Postpartum state | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Ultrasound scan abnormal | · | · | ✓ |
| SRO | Herpes zoster | ○ | ○ | ○ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release